20 research outputs found
Association between pS2 and cathepsin-D in breast carcinoma: biological and clinical aspects
No full textSimultaneous determination of steroid hormone receptors and estrogen-regulated proteins pS2 and cathepsin D in breast carcinomas
No full text
Very high steroid receptor content in postmenopausal breast cancer patient: The unfavorable predictive factor?
No full text
Different EGF-R content in primary breast carcinomas, metastatic lymph nodes and invaded skin: The tissue characteristics or the breast carcinoma biological property?
No full textThe influence of classical prognostic factors and adjuvant chemotherapy on disease outcome in early grade 3 node-negative, and 1ā3 node-positive breast cancer patients treated with adjuvant cyclophosphamide, methotrexate and fluorouracil (CMF), or untreated patients
No full text
Three-dimensional total synchronous luminescence spectroscopy criteria for discrimination between normal and malignant breast tissues
No full textSpecimens of malignant and normal female human breast tissues were analyzed after surgery by means of synchronous luminescence spectroscopy. Measurements were performed in the ranges of excitation wavelengths from 330 to 650 nm and synchronous wavelengths from 30 to 120 nm to obtain ordinary and first derivative three-dimensional total synchronous luminescence spectra (3d-TSLS) of each specimen. Arithmetic mean of these spectra has been calculated for normal and malignant specimens and analyzed to establish criteria for tissue differentiation. Spectral domain volumes (volumes below luminescence intensity surface) and mean spectral slopes have been calculated and also analyzed as tissue discrimination criteria. The obtained results are discussed in view of the possible relevance of synchronous luminescence spectroscopy in discrimination between normal and malignant breast tissue
